Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rabah Benrabah

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Ophthalmology|March 5, 2005
Short-term tolerance of pulse methylprednisolone therapy in patients with diabetes mellitusSylvie Feldman-Billard, Bruno Lissak, Roxana Kassaei, et al.
Ophthalmology|December 4, 2003
Intravenous pulse methylprednisolone therapy in eye disease: effect on glucose toleranceSylvie Feldman-Billard, Bruno Lissak, Rabah Benrabah, et al.
Ocular Immunology and Inflammation|February 24, 2016
Multiple Sclerosis-related Uveitis: Does MS Treatment Affect Uveitis Course?Léa Jouve, Rabah Benrabah, Emmanuel Héron, et al.
Journal of Neurology|February 8, 2019
Five-year outcome in the copaxone observatory: a nationwide cohort of patients with multiple sclerosis starting treatment with glatiramer acetate in FranceChristine Lebrun-Frenay, Antoine Moulignier, Charles Pierrot-Deseilligny, et al.
BMC Neurology|June 14, 2012
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot studyPatrick Vermersch, Rabah Benrabah, Nicolas Schmidt, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Ophthalmology|March 5, 2005
Short-term tolerance of pulse methylprednisolone therapy in patients with diabetes mellitusSylvie Feldman-Billard, Bruno Lissak, Roxana Kassaei, et al.
Ophthalmology|December 4, 2003
Intravenous pulse methylprednisolone therapy in eye disease: effect on glucose toleranceSylvie Feldman-Billard, Bruno Lissak, Rabah Benrabah, et al.
Ocular Immunology and Inflammation|February 24, 2016
Multiple Sclerosis-related Uveitis: Does MS Treatment Affect Uveitis Course?Léa Jouve, Rabah Benrabah, Emmanuel Héron, et al.
Journal of Neurology|February 8, 2019
Five-year outcome in the copaxone observatory: a nationwide cohort of patients with multiple sclerosis starting treatment with glatiramer acetate in FranceChristine Lebrun-Frenay, Antoine Moulignier, Charles Pierrot-Deseilligny, et al.
BMC Neurology|June 14, 2012
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot studyPatrick Vermersch, Rabah Benrabah, Nicolas Schmidt, et al.
Pageof 1